Archives of Cardiovascular Diseases

Papers
(The H4-Index of Archives of Cardiovascular Diseases is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Obstructive sleep apnoea and cardiovascular consequences: Pathophysiological mechanisms105
One train may hide another: Acute cardiovascular diseases could be neglected because of the COVID-19 pandemic56
Worrying decrease in hospital admissions for myocardial infarction during the COVID-19 pandemic42
Triglycerides and risk of atherosclerotic cardiovascular disease: An update41
D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study30
Diagnostic accuracy of smart gadgets/wearable devices in detecting atrial fibrillation: A systematic review and meta-analysis24
The role of hyperglycaemia in the development of diabetic cardiomyopathy24
COVID-19 vaccines and myocarditis24
Heart failure with preserved ejection fraction: A clustering approach to a heterogenous syndrome22
Successful linkage of French large-scale national registry populations to national reimbursement data: Improved data completeness and minimized loss to follow-up21
Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study21
Practical management of worsening renal function in outpatients with heart failure and reduced ejection fraction: Statement from a panel of multidisciplinary experts and the Heart Failure Working Grou21
Colchicine and myocardial infarction: A review19
Left atrial dysfunction as marker of poor outcome in patients with hypertrophic cardiomyopathy18
TAVI in 2022: Remaining issues and future direction18
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France16
Myocardial glucotoxicity: Mechanisms and potential therapeutic targets16
0.085383892059326